A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease

Дата публикации: 07-08-2026 00:58:03

The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	STAT+: Novo Nordisk inflammation-targeting drug misses mark in heart disease study	0	7.41	31-07-2026
2	STAT+: AstraZeneca, Ionis report major trial failure with heart disease drug	-2	7	09-07-2026
3	New, sophisticated drugs did not move the needle on hearts attacks, strokes: what this teaches us	0	6.4	20-09-2026
4	Herz-Medikament: Novo Nordisk mit Entwicklungsfehlschlag – Aktienkurs sackt ab	0	12.84	31-07-2026
5	What is pulmonary hypertension and why would a new GLP-1 help?	0	5	26-06-2026
6	Kidney cancer drug could slash the risk of repeated heart attacks in a similar way to statins, study suggests	0	8.9	01-09-2024
7	National Institutes of Health testing controversial Covid drug as new cancer treatment	0	8.01	11-02-2026
8	Акции западного фармгиганта обвалились после неудачных испытаний лекарства	-3	6	09-07-2026
9	Researchers identify immune trigger behind myocarditis after COVID-19 vaccination	0	9.44	15-12-2025
10	This 10-cent heart drug cuts hospitalizations by 25%	0	16.47	16-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.7. Источник: www.nytimes.com.